The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.

NCT04026841 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Affiliated Hospital of Guangzhou Medical University